Renal Function in Type 2 Diabetes Following Gastric Bypass.

Journal: Deutsches Arzteblatt international
Published Date:

Abstract

BACKGROUND: Metabolic surgery for obese patients with type 2 diabetes (T2D) yields short- and long-term remission rates of 60-90%. Its effects on diabetesassociated complications such as neuropathy and nephropathy have not been well studied to date. Hardly any data are available on this subject with respect to moderately obese patients (body mass index [BMI] 25-35 kg/m2) with insulin-dependent T2D. Our previous studies suggest that, in such patients, treatment with a Roux-en-Y gastric bypass (RYGB) improves diabetic neuropathy. In this pilot study, we investigate the course of diabetic nephropathy after RYGB surgery.

Authors

  • Adrian T Billeter
    Department of General, Visceral and Transplantation Surgery at Heidelberg University Hospital; Department of Endocrinology, Metabolism and Clinical Chemistry at Heidelberg University Hospital, Heidelberg.
  • Stefan Kopf
  • Martin Zeier
  • Katharina Scheurlen
  • Lars Fischer
  • Thilo M Schulte
  • Hannes G Kenngott
  • Barbara Israel
  • Philipp Knefeli
  • Markus W Büchler
  • Peter P Nawroth
  • Beat P Müller-Stich